Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2020

Apr 16, 2020

33003_dirs_2020-04-16_0a934a32-139a-43db-8308-7e638d652c87.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-04-15

Reporting Person: SMITH IAN F (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $3.24 2030-02-10 Common Stock (60000) Direct

Footnotes

F1: This option was granted on February 10, 2020 and vests in full July 31, 2020, subject to continued service as a consultant.